Q4 2022 Swedish Orphan Biovitrum AB (publ) Earnings Call Transcript
Ladies and gentlemen, welcome to the Sobi Q4 2022 report. (Operator Instructions) I will now hand over to the company.
()-&
Yes. Thank you so much, and hello, everyone. This is your CEO. So we welcome to the Fourth Quarter Full Year 2022 Conference Call for Investors And Analysts.
The presentation was posted to sobi.com earlier. Let's go to slide number 2. Slide 2 has the usual safe harbor statement. Unless stated otherwise, we will be making comments that mostly relate to fourth quarter performance in 2022 at constant exchange rates and in million Swedish krona as per usual.
Please turn to Slide #3. This is the agenda where we plan to cover all key aspects of the report today. We plan to review the presentation first and then go to the Q&A until around 2:00 Swedish time. If you keep your questions short, we will try to be on until 3. (Operator Instructions)
In speaking order, I'm joined by Henrik, our CFO; Anders,
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |